IPC and CSIR-CIMAP renew collaboration to advance Medicinal Plant Research
Published: Jul 24, 2026

By TIOLCorplaws News Service
NEW DELHI, JULY 24, 2026: THE Indian Pharmacopoeia Commission (IPC), an autonomous institution under the Ministry of Health & Family Welfare, Government of India, reinforced its commitment to the vision of Viksit UP-Viksit Bharat by signing and renewing two Memoranda of Understanding (MoUs) with Dr. Shakuntala Misra National Rehabilitation University (DSMNRU), Lucknow, and CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP).
The ceremony was attended by Prof. Sanjay Singh, Vice-Chancellor, DSMNRU, Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, IPC, and senior officials from CSIR-CIMAP.
The renewed MoU with CSIR-CIMAP will continue collaboration in medicinal plant research, standardization, and quality evaluation of herbal medicines.
The new MoU with DSMNRU will focus on developing scientific protocols for assessing the quality, safety, and performance of assistive devices used by persons with disabilities. The collaboration will also support the development of a pharmacovigilance training module in sign language to enhance medicine safety awareness and adverse drug reaction reporting among persons with disabilities.
Speaking on the occasion, Dr. V. Kalaiselvan said that these collaborations will strengthen scientific research, quality standards, and institutional partnerships, supporting Uttar Pradesh's emergence as a centre of excellence in healthcare and pharmaceutical quality. He emphasized that such initiatives contribute directly to the shared vision of Viksit UP-Viksit Bharat by improving access to safe, effective, and quality healthcare products.
These partnerships reaffirm IPC's commitment to advancing quality healthcare, scientific innovation, and capacity building in support of national healthcare priorities.